knowledge -WSS

knowledge

author：entertainment 2025-09-06 04:41:59 - browse：9

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Readout LOUD podcast: ALS dilemma, first MASH drug, and more

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

Liz Cheney makes 1st public comment since Trump's election interference indictments

ActiGraph execs on goal of drug approvals with digital endpoints

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Medicare coverage of Wegovy, once blocked, now looks possible

RaDonda Vaught links Vanderbilt hospital issues to patient death

hotspot

knowledge

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

Steward Health Care Massachusetts hospitals face fiscal disaster

Peter Hotez and the public health issue of online harassment

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Duchenne breakthrough therapy leaves behind pioneering families

FDA approves first treatment for ultra

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The pain doctors face in trying to build their families

FDA approval of Sarepta Duchenne genetic therapy gives me hope

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

hotspot

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Hilary expected to bring catastrophic, life

Hilary expected to bring catastrophic, life

UCLA team creates talking throat patch for voice disorders

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

FDA advisers back CAR

leisure time

hotspot

focus

leisure time